Native Antigen Introduces Novel Coronavirus Antigens
The newly developed recombinant antigens derived specifically from COVID-19 are intended for use in infectious disease research, and assay and vaccine development.
Read More
Search Results for: covid-19
HHS Seeks Abstract Submissions for 2019-nCoV Diagnostics Development
The Biomedical Advanced Research and Development Authority will review submissions from organizations seeking to develop molecular diagnostics for 2019-nCoV.
Read More
FDA Issues Emergency Use Authorization for the First 2019 Novel Coronavirus Diagnostic
Critical milestone reached in response to the Wuhan coronavirus outbreak.
Read More
Inside Track: Coronavirus Diagnostics
Labs gear up to do battle with a potent pathogen.
Read More